Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/15/1994 | WO1994020095A1 Biologically active ureido derivatives useful as antimetastatic agents |
09/15/1994 | WO1994020093A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
09/15/1994 | WO1994020092A1 Calcium antagonist |
09/15/1994 | WO1994020091A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
09/15/1994 | WO1994020089A1 Taxol-based compositions with enhanced bioactivity |
09/15/1994 | WO1994020088A1 C9 taxane derivatives and pharmaceutical compositions containing them |
09/15/1994 | WO1994020087A1 Throat compositions |
09/15/1994 | WO1994020086A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
09/15/1994 | WO1994020085A1 Methods and compositions for inhibition of angiogenesis |
09/15/1994 | WO1994020084A1 Antiviral compositions containing a combination of an iodide of dimethylbenzylalkylammonium with an iodide of a quaternary ammonium amide |
09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
09/15/1994 | WO1994020082A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
09/15/1994 | WO1994020081A1 Anhydroretinol and derivatives thereof as antagonists |
09/15/1994 | WO1994020080A1 Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer |
09/15/1994 | WO1994020077A1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
09/15/1994 | WO1994020068A1 Composition and method for whitening skin |
09/15/1994 | WO1994020067A1 Dimeric acids in cosmetic or pharmaceutical compositions |
09/15/1994 | WO1994020062A2 Balanoids as protein kinase c inhibitors |
09/15/1994 | WO1994019948A1 Chemoprotective isothiocyanates |
09/15/1994 | WO1994019946A1 Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin |
09/15/1994 | WO1994019945A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
09/15/1994 | WO1994019943A1 Ionene polymers as microbicides |
09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
09/15/1994 | WO1994016705A3 Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders |
09/15/1994 | WO1994015598A3 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
09/15/1994 | CA2158050A1 Method and apparatus for extracting taxol from source materials |
09/15/1994 | CA2157934A1 Eye care products containing a pheromone additive and method of using the same |
09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
09/15/1994 | CA2157801A1 Antitumor compositions and methods of treatment |
09/15/1994 | CA2157798A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
09/15/1994 | CA2157671A1 Medicament for treating or preventing cerebrovascular diseases |
09/15/1994 | CA2157594A1 Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants |
09/15/1994 | CA2157580A1 Heterocyclic compounds and their preparation and use |
09/15/1994 | CA2157488A1 Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
09/15/1994 | CA2157412A1 Balanoids |
09/15/1994 | CA2157383A1 Optical isomerization inhibitor |
09/15/1994 | CA2157363A1 15-substituted 4-azasteroids |
09/15/1994 | CA2157359A1 New o-sulfated gangliosides and lyso-ganglioside derivatives |
09/15/1994 | CA2157357A1 New sulfated lyso-ganglioside derivatives |
09/15/1994 | CA2157295A1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
09/15/1994 | CA2157215A1 New 4-aminopyridines - processes for their production as well as pharmaceutical agents containing them |
09/15/1994 | CA2157190A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
09/15/1994 | CA2157187A1 Novel distamycin analogues |
09/15/1994 | CA2157037A1 Benzylimidazopyridine derivatives as angiotensin ii receptor antagonists |
09/15/1994 | CA2156729A1 New 4-aminopyridines, processes for their production as well as pharmaceutical agents containing these compounds |
09/15/1994 | CA2156410A1 Pyrrolo-pyridine derivatives |
09/15/1994 | CA2156409A1 Quinolone derivatives as dopamine d4 ligands |
09/15/1994 | CA2156389A1 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use thereof as excitatory amino acid and glycine receptor antagonists |
09/15/1994 | CA2154573A1 Use of anticonvulsants for the treatment of neuro-sida |
09/15/1994 | CA2154571A1 Use of lamotrigine for the treatment of neuro-sida |
09/15/1994 | CA2154355A1 Recombinant virus and their use in gene therapy |
09/15/1994 | CA2153951A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-one-1,1-dioxide derivatives as non- competitive nmda receptor antagonists |
09/15/1994 | CA2153895A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
09/15/1994 | CA2153577A1 Method for preparing n-methyl 2-(3-pyridyl)(1r,2r)-2-tetrahydrothiopyrancarbothioamide-1-oxide |
09/15/1994 | CA2152400A1 New 2-phenoxyethanamine derivatives; process for preparing them and their use as therapeutic agents |
09/15/1994 | CA2134880A1 Graft rejection inhibitor and il-1 production inhibitor |
09/15/1994 | CA2134098A1 Biologically active ureido derivatives useful as antimetastatic agents |
09/15/1994 | CA2118422A1 2 acyloxycephem derivatives |
09/14/1994 | EP0614911A1 Compounds having a sulfonamide and an amidinegroup, process for preparation and pharmaceutical compositions comprising them |
09/14/1994 | EP0614907A1 Dinucleotide and oligonucleotide analogues |
09/14/1994 | EP0614905A1 Erythromycin derivatives, their process of preparation and their application as medicaments |
09/14/1994 | EP0614899A1 5-Phenyl-pyrrolo-1,4-benzoxazine and thiazine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
09/14/1994 | EP0614898A1 Indole derivative, process for producing the same, and medicinal use thereof |
09/14/1994 | EP0614896A1 Esculetin derivatives and pharmaceutical composition |
09/14/1994 | EP0614894A1 Process for the synthesis of substituted amide derivatives of piperazinylcamphorsulfonyl oxytocin antagonists |
09/14/1994 | EP0614893A1 Benzoazine derivatives, their preparation and their use in therapy |
09/14/1994 | EP0614888A1 Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments |
09/14/1994 | EP0614887A1 Indole-sulfonamides as antitumor agents |
09/14/1994 | EP0614663A1 Pharmaceutical composition containing a general anaesthetic and selegiline |
09/14/1994 | EP0614662A1 Use of (2E,4E,6E,10E)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid for the treatment of leukaemia |
09/14/1994 | EP0614661A2 Benzylidene- and cinnamylidine-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells |
09/14/1994 | EP0614659A2 Pharmaceutical compositions in semisolid form and a device for administration thereof |
09/14/1994 | EP0614616A2 Composition for treating patients with hepatic disease |
09/14/1994 | EP0614463A1 Angiostatic steroids |
09/14/1994 | EP0614457A1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments. |
09/14/1994 | EP0614456A1 1$g(a),24(S)-DIHYDROXY VITAMIN D 2?, ITS FORMATION AND USE |
09/14/1994 | EP0614367A1 Substituted lactose and lactosamine derivatives as cell adhesion inhibitors |
09/14/1994 | EP0614366A1 Use of creatine phosphate or phosphoenolpyruvic acid for the treatment of tumours. |
09/14/1994 | EP0614365A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application |
09/14/1994 | EP0614364A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin |
09/14/1994 | EP0614363A1 Quinolone derivatives |
09/14/1994 | EP0614361A1 Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals |
09/14/1994 | EP0614359A1 Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
09/14/1994 | EP0614358A1 Process and composition for the development of controlled release gemfibrozil dosage form |
09/14/1994 | EP0614357A1 Immunopotentiatory agents |
09/14/1994 | EP0614354A1 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
09/14/1994 | EP0614353A1 Compositions for regulating skin wrinkles and/or skin atrophy |
09/14/1994 | EP0571485B1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
09/14/1994 | EP0566592B1 Pyrimido-benzothiazines with lipoxygenase inhibitory action |
09/14/1994 | EP0540623B1 Oral osmotic device for delivering nicotine |
09/14/1994 | EP0536151B1 Orthosubstituted biphenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them |
09/14/1994 | EP0489032B1 Hydroxamic acid based collagenase inhibitors |
09/14/1994 | EP0484378B1 Antiarrhythmic tertiary amine-alkenyl-phenyl-alkanesulfonamides |
09/14/1994 | EP0475994B1 Macrolides for the treatment of reversible obstructive airways diseases |
09/14/1994 | EP0221176B1 Pharmaceutical vehicles for recucing transdermal flux |
09/14/1994 | CN1092074A Diazepine derivatives |
09/14/1994 | CN1092072A Pharmaceutical compounds |
09/14/1994 | CN1092071A Spiro piperidines and homologs which promote release of growth hormone |
09/14/1994 | CN1092068A Alkoxymethyl-substituted pyridonebiphenyls |